Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Abuse
Biotech
Tris shows its opioid alternative is less likely to be abused
Having shown its opioid alternative can reduce pain, Tris is back with another slice of clinical data to show the drug is less likely to be abused.
James Waldron
Jan 28, 2025 10:53am
Pear to take digital treatments physical with wearables deals
Apr 6, 2021 1:45pm
Orexo, GoGoMeds pair up on digital addiction, depression apps
Sep 10, 2020 3:05pm
Novartis' Sandoz drops out of prescription app deal with Pear
Oct 16, 2019 9:42am
Tonix boosts pipeline with cocaine intoxication drug
May 23, 2019 9:03am
Cash reserves running low at KemPharm
Mar 30, 2018 8:23am
